The multiple facets of FcRn in immunity

Immunological Reviews

Volumn 268, Issue 1, 2015, Pages 253-268

  Stapleton, Nigel M ^a   Einarsdóttir, Helga K ^a   Stemerding, Annette M ^b   Vidarsson, Gestur ^a  

^a SANQUIN RESEARCH   (Netherlands)

^b GELRE HOSPITALS   (Netherlands)

Author keywords

FcRn; Half life; Myeloid cells; Neonatal Fc receptor; Phagocytosis

Indexed keywords

ALBUMIN; FC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G3; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; NEONATAL FC RECEPTOR; TRANSFERRIN RECEPTOR; TRYPTOPHAN; UNCLASSIFIED DRUG; FC RECEPTOR, NEONATAL; HLA ANTIGEN CLASS 1; PROTEIN BINDING;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; BINDING SITE; EPITHELIUM CELL; HALF LIFE TIME; HUMAN; HUMORAL IMMUNITY; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; NEWBORN; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR BINDING; REVIEW; STOICHIOMETRY; STRUCTURE ACTIVITY RELATION; TRANSCYTOSIS; AGE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; HOST PATHOGEN INTERACTION; IMMUNITY; IMMUNOLOGY; METABOLISM; PHAGOCYTOSIS; PROTEIN CONFORMATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

AGE FACTORS; ANIMALS; ANTIGEN PRESENTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; IMMUNOGLOBULIN G; MODELS, MOLECULAR; PHAGOCYTOSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN TRANSPORT; RECEPTORS, FC; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCYTOSIS;

EID: 84945290743     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12331     Document Type: Review

References (180)

1. Mechnikov I. On the present state of the question of immunity in infectious diseases. Available from http://www.nobelprize.org/nobel_prizes/medicine/laureates/1908/mechnikov-lecture.html (accessed July 20, 2015), 1908.
2. Nossal GJ, Lederberg J. Antibody production by single cells. Nature 1958;181:1419-1420.
3. Sakano H, Kurosawa Y, Weigert M, Tonegawa S. Identification and nucleotide sequence of a diversity DNA segment (D) of immunoglobulin heavy-chain genes. Nature 1981;290:562-565.
4. Boyden SV. Cytophilic antibody in guinea-pigs with delayed-type hypersensitivity. Immunology 1964;7:474-483.
5. Boyden SV, Sorkin E. The adsorption of antigen by spleen cells previously treated with antiserum invitro. Immunology 1960;3:272-283.
6. Anderson CL, Grey HM. Receptors for aggregated IgG on mouse lymphocytes: their presence on thymocytes, thymus-derived, and bone marrow-derived lymphocytes. J Exp Med 1974;139:1175-1188.
7. Lawrence DA, Weigle WO, Spiegelberg HL. Immunoglobulins cytophilic for human lymphocytes, monocytes, and neutrophils. J Clin Invest 1975;55:368-376.
8. Mellman IS, Unkeless JC. Purification of a functional mouse Fc receptor through the use of a monoclonal antibody. J Exp Med 1980;152:1048-1069.
9. Lewis VA, Koch T, Plutner H, Mellman I. A complementary DNA clone for a macrophage-lymphocyte Fc receptor. Nature 1986;324:372-375.
10. Hibbs ML, etal. The murine Fc receptor for immunoglobulin: purification, partial amino acid sequence, and isolation of cDNA clones. Proc Natl Acad Sci USA 1986;83:6980-6984.
11. Nimmerjahn F, Bruhns P, Horiuchi K, Ravetch JV. FcgammaRIV: a novel FcR with distinct IgG subclass specificity. Immunity 2005;23:41-51.
12. Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Annu Rev Immunol 2002;20:825-852.
13. Brambell FW, Hemmings WA, Morris IG. A theoretical model of gamma-globulin catabolism. Nature 1964;203:1352-1354.
14. Brambell FW. The transmission of immunity from mother to young and the catabolism of immunoglobulins. Lancet 1966;2:1087-1093.
15. Ghetie V, Hubbard JG, Kim JK, Tsen MF, Lee Y, Ward ES. Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice. Eur J Immunol 1996;26:690-696.
16. Israel EJ, Wilsker DF, Hayes KC, Schoenfeld D, Simister NE. Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn. Immunology 1996;89:573-578.
17. Junghans RP, Anderson CL. The protection receptor for IgG catabolism is the beta2- microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci USA 1996;93:5512-5516.
18. Roopenian DC, etal. The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J Immunol 2003;170:3528-3533.
19. Simister NE, Story CM, Chen HL, Hunt JS. An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta. Eur J Immunol 1996;26:1527-1531.
20. Simister NE, Mostov KE. An Fc receptor structurally related to MHC class I antigens. Nature 1989;337:184-187.
21. Chaudhury C, etal. The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med 2003;197:315-322.
22. Anderson CL, Chaudhury C, Kim J, Bronson CL, Wani MA, Mohanty S. Perspective - FcRn trans-ports albumin: relevance to immunology and medicine. Trends Immunol 2006;27:343-348.
23. Spiekermann GM, etal. Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J Exp Med 2002;196:303-310.
24. Yoshida M, etal. Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. J Clin Invest 2006;116:2142-2151.
25. Zhu X, etal. MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J Immunol 2001;166:3266-3276.
26. Sachs UJ, Socher I, Braeunlich CG, Kroll H, Bein G, Santoso S. A variable number of tandem repeats polymorphism influences the transcriptional activity of the neonatal Fc receptor alpha-chain promoter. Immunology 2006;119:83-89.
27. Vidarsson G, etal. FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis. Blood 2006;108:3573-3579.
28. Baker K, Rath T, Pyzik M, Blumberg RS. The role of FcRn in antigen presentation. Front Immunol 2014;5:408.
29. Qiao SW, etal. Dependence of antibody-mediated presentation of antigen on FcRn. Proc Natl Acad Sci USA 2008;105:9337-9342.
30. Kuo TT, etal. N-glycan moieties in neonatal Fc receptor determine steady-state membrane distribution and directional transport of IgG. J Biol Chem 2009;284:8292-8300.
31. Dickinson BL, etal. Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J Clin Invest 1999;104:903-911.
32. West AP Jr, Bjorkman PJ. Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor(, ). Biochemistry 2000;39:9698-9708.
33. Chaudhury C, Brooks CL, Carter DC, Robinson JM, Anderson CL. Albumin binding to FcRn: distinct from the FcRn-IgG interaction. Biochemistry 2006;45:4983-4990.
34. Dee Qian J, Andersen JT, Sandlie I. The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin. Eur J Immunol 2006;36:3044-3051.
35. Sand KM, etal. Dissection of the neonatal Fc receptor (FcRn)-albumin interface using mutagenesis and anti-FcRn albumin-blocking antibodies. J Biol Chem 2014;289:17228-17239.
36. Lencer WI, Blumberg RS. A passionate kiss, then run: exocytosis and recycling of IgG by FcRn. Trends Cell Biol 2005;15:5-9.
37. Gastinel LN, Simister NE, Bjorkman PJ. Expression and crystallization of a soluble and functional form of an Fc receptor related to class I histocompatibility molecules. Proc Natl Acad Sci USA 1992;89:638-642.
38. Burmeister WP, Huber AH, Bjorkman PJ. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature 1994;372:379-383.
39. Shields RL, etal. High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. J Biol Chem 2001;276:6591-6604.
40. Zhu X, Peng J, Raychowdhury R, Nakajima A, Lencer WI, Blumberg RS. The heavy chain of neonatal Fc receptor for IgG is sequestered in endoplasmic reticulum by forming oligomers in the absence of beta2-microglobulin association. Biochem J 2002;367:703-714.
41. Praetor A, Jones RM, Wong WL, Hunziker W. Membrane-anchored human FcRn can oligomerize in the absence of IgG. J Mol Biol 2002;321:277-284.
42. Praetor A, Hunziker W. beta(2)-Microglobulin is important for cell surface expression and pH-dependent IgG binding of human FcRn. J Cell Sci 2002;115:2389-2397.
43. Stapleton NM, etal. Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. Nat Commun 2011;2:599.
44. Ober RJ, Martinez C, Vaccaro C, Zhou J, Ward ES. Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn. J Immunol 2004;172:2021-2029.
45. Tesar DB, Bjorkman PJ. An intracellular traffic jam: Fc receptor-mediated transport of immunoglobulin G. Curr Opin Struct Biol 2010;20:226-233.
46. He W, Ladinsky MS, Huey-Tubman KE, Jensen GJ, McIntosh JR, Bjorkman PJ. FcRn-mediated antibody transport across epithelial cells revealed by electron tomography. Nature 2008;455:542-546.
47. Berryman M, Rodewald R. Beta 2-microglobulin co-distributes with the heavy chain of the intestinal IgG-Fc receptor throughout the transepithelial transport pathway of the neonatal rat. J Cell Sci 1995;108(Pt 6):2347-2360.
48. Claypool SM, etal. Bi-directional transepithelial IgG transport by a strongly polarized basolateral membrane Fc{gamma}-receptor. Mol Biol Cell 2004;15:1746-1759.
49. Wu Z, Simister NE. Tryptophan- and dileucine-based endocytosis signals in the neonatal Fc receptor. J Biol Chem 2001;276:5240-5247.
50. McCarthy KM, etal. Effects of mutations in potential phosphorylation sites on transcytosis of FcRn. J Cell Sci 2001;114:1591-1598.
51. Kristoffersen EK, Matre R. Co-localization of beta 2-microglobulin and IgG in human placental syncytiotrophoblasts. Eur J Immunol 1996;26:505-507.
52. Leach JL, Sedmak DD, Osborne JM, Rahill B, Lairmore MD, Anderson CL. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. J Immunol 1996;157:3317-3322.
53. Story CM, Mikulska JE, Simister NE. A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus. J Exp Med 1994;180:2377-2381.
54. Cianga P, Cianga C, Cozma L, Ward ES, Carasevici E. The MHC class I related Fc receptor, FcRn, is expressed in the epithelial cells of the human mammary gland. Hum Immunol 2003;64:1152-1159.
55. Cianga P, Medesan C, Richardson JA, Ghetie V, Ward ES. Identification and function of neonatal Fc receptor in mammary gland of lactating mice. Eur J Immunol 1999;29:2515-2523.
56. Yoshida M, etal. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 2004;20:769-783.
57. Tesar DB, Tiangco NE, Bjorkman PJ. Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor. Traffic 2006;7:1127-1142.
58. He Y, Jensen GJ, Bjorkman PJ. Nanogold as a specific marker for electron cryotomography. Microsc Microanal 2009;15:183-188.
59. Andersen JT, etal. Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor. Nat Commun 2012;3:610.
60. Oganesyan V, etal. Structural insights into neonatal Fc receptor-based recycling mechanisms. J Biol Chem 2014;289:7812-7824.
61. John TA, Vogel SM, Minshall RD, Ridge K, Tiruppathi C, Malik AB. Evidence for the role of alveolar epithelial gp60 in active transalveolar albumin transport in the rat lung. J Physiol 2001;533:547-559.
62. Schnitzer JE. gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis. Am J Physiol 1992;262:H246-H254.
63. Vogel SM, Minshall RD, Pilipovic M, Tiruppathi C, Malik AB. Albumin uptake and transcytosis in endothelial cells invivo induced by albumin-binding protein. Am J Physiol Lung Cell Mol Physiol 2001;281:L1512-L1522.
64. Datta-Mannan A, etal. Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics. MAbs 2015;7:483-493.
65. Igawa T, etal. Reduced elimination of IgG antibodies by engineering the variable region. Protein Eng Des Sel 2010;23:385-392.
66. Li B, etal. Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule charge. MAbs 2014;6:1255-1264.
67. Borrok MJ, etal. pH-dependent binding engineering reveals an FcRn affinity threshold that governs IgG recycling. J Biol Chem 2015;290:4282-4290.
68. Ishii-Watabe A, etal. Genetic polymorphisms of FCGRT encoding FcRn in a Japanese population and their functional analysis. Drug Metab Pharmacokinet 2010;25:578-587.
69. Wani MA, etal. Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant beta2-microglobulin gene. Proc Natl Acad Sci USA 2006;103:5084-5089.
70. Gouilleux-Gruart V, etal. Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor. Clin Exp Immunol 2013;171:186-194.
71. Passot C, etal. Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies. MAbs 2013;5:614-619.
72. Ober RJ, Martinez C, Lai X, Zhou J, Ward ES. Exocytosis of IgG as mediated by the receptor, FcRn: an analysis at the single-molecule level. Proc Natl Acad Sci USA 2004;101:11076-11081.
73. Wernick NL, Haucke V, Simister NE. Recognition of the tryptophan-based endocytosis signal in the neonatal Fc Receptor by the mu subunit of adaptor protein-2. J Biol Chem 2005;280:7309-7316.
74. Bonifacino JS, Traub LM. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem 2003;72:395-447.
75. Adamski FM, King AT, Demmer J. Expression of the Fc receptor in the mammary gland during lactation in the marsupial Trichosurus vulpecula (brushtail possum). Mol Immunol 2000;37:435-444.
76. Stefaner I, Praetor A, Hunziker W. Nonvectorial surface transport, endocytosis via a Di-leucine-based motif, and bidirectional transcytosis of chimera encoding the cytosolic tail of rat FcRn expressed in Madin-Darby canine kidney cells. J Biol Chem 1999;274:8998-9005.
77. Bremnes T, Lauvrak V, Lindqvist B, Bakke O. A region from the medium chain adaptor subunit (mu) recognizes leucine- and tyrosine-based sorting signals. J Biol Chem 1998;273:8638-8645.
78. Rodionov DG, Bakke O. Medium chains of adaptor complexes AP-1 and AP-2 recognize leucine-based sorting signals from the invariant chain. J Biol Chem 1998;273:6005-6008.
79. Rohde G, Wenzel D, Haucke V. A phosphatidylinositol (4, 5)-bisphosphate binding site within mu2-adaptin regulates clathrin-mediated endocytosis. J Cell Biol 2002;158:209-214.
80. Heilker R, Manning-Krieg U, Zuber JF, Spiess M. In vitro binding of clathrin adaptors to sorting signals correlates with endocytosis and basolateral sorting. EMBO J 1996;15:2893-2899.
81. Glickman JN, Conibear E, Pearse BM. Specificity of binding of clathrin adaptors to signals on the mannose-6-phosphate/insulin-like growth factor II receptor. EMBO J 1989;8:1041-1047.
82. Ye L, etal. The MHC class II-associated invariant chain interacts with the neonatal Fc gamma receptor and modulates its trafficking to endosomal/lysosomal compartments. J Immunol 2008;181:2572-2585.
83. Kirchhausen T, Bonifacino JS, Riezman H. Linking cargo to vesicle formation: receptor tail interactions with coat proteins. Curr Opin Cell Biol 1997;9:488-495.
84. 2+-dependent calmodulin binding to FcRn affects immunoglobulin G transport in the transcytotic pathway. Mol Biol Cell 2008;19:414-423.
85. Israel EJ, Patel VK, Taylor SF, Marshak-Rothstein A, Simister NE. Requirement for a beta 2-microglobulin-associated Fc receptor for acquisition of maternal IgG by fetal and neonatal mice. J Immunol 1995;154:6246-6251.
86. Einarsdottir HK, etal. Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G. Glycoconj J 2013;30:147-157.
87. Antohe F, Radulescu L, Gafencu A, Ghetie V, Simionescu M. Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. Hum Immunol 2001;62:93-105.
88. Einarsdottir H, etal. H435-containing immunoglobulin G3 allotypes are transported efficiently across the human placenta: implications for alloantibody-mediated diseases of the newborn. Transfusion 2014;54:665-671.
89. Mathiesen L, etal. Maternofetal transplacental transport of recombinant IgG antibodies lacking effector functions. Blood 2013;122:1174-1181.
90. Kim J, etal. FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus. J Immunol 2009;182:2583-2589.
91. Ladinsky MS, Huey-Tubman KE, Bjorkman PJ. Electron tomography of late stages of FcRn-mediated antibody transcytosis in neonatal rat small intestine. Mol Biol Cell 2012;23:2537-2545.
92. Horton RE, Vidarsson G. Antibodies and their receptors: different potential roles in mucosal defense. Front Immunol 2013;4:200.
93. Shah U, Dickinson BL, Blumberg RS, Simister NE, Lencer WI, Walker WA. Distribution of the IgG Fc receptor, FcRn, in the human fetal intestine. Pediatr Res 2003;53:295-301.
94. Mohanty S, etal. IgG is transported across the mouse yolk sac independently of FcgammaRIIb. J Reprod Immunol 2010;84:133-144.
95. Firan M, etal. The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans. Int Immunol 2001;13:993-1002.
96. Roopenian DC, Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 2007;7:715-725.
97. Anderson CL. There's been a flaw in our thinking. Front Immunol 2014;5:540.
98. Morell A, Terry WD, Waldmann TA. Metabolic properties of IgG subclasses in man. J Clin Invest 1970;49:673-680.
99. Malek A, Sager R, Kuhn P, Nicolaides KH, Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol 1996;36:248-255.
100. Einarsdottir HK, etal. On the perplexingly low rate of transport of IgG2 across the human placenta. PLoS ONE 2014;9:e108319.
101. Burmeister WP, Gastinel LN, Simister NE, Blum ML, Bjorkman PJ. Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor. Nature 1994;372:336-343.
102. Kim JK, Firan M, Radu CG, Kim CH, Ghetie V, Ward ES. Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn. Eur J Immunol 1999;29:2819-2825.
103. Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol 2014;5:520.
104. de Lange GG. Polymorphisms of human immunoglobulins: Gm, Am, Em and Km allotypes. Exp Clin Immunogenet 1989;6:7-17.
105. Lefranc MP, Lefranc G. Human Gm, Km, and Am allotypes and their molecular characterization: a remarkable demonstration of polymorphism. Methods Mol Biol 2012;882:635-680.
106. Hassan MS, Abedi-Valugerdi M, Lefranc G, Hammarstrom L, Smith CI. Biological half-life of normal and truncated human IgG3 in scid mice. Eur J Immunol 1991;21:1319-1322.
107. Bruhns P, etal. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 2009;113:3716-3725.
108. Rosner T, etal. An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumour cells with low CD20 expression levels. Br J Haematol 2013;161:282-286.
109. Overdijk MB, etal. Crosstalk between human IgG isotypes and murine effector cells. J Immunol 2012;189:3430-3438.
110. Simister NE. Placental transport of immunoglobulin G. Vaccine 2003;21:3365-3369.
111. Tzaban S, etal. The recycling and transcytotic pathways for IgG transport by FcRn are distinct and display an inherent polarity. J Cell Biol 2009;185:673-684.
112. Newton EE, Wu Z, Simister NE. Characterization of basolateral-targeting signals in the neonatal Fc receptor. J Cell Sci 2005;118:2461-2469.
113. Gurbaxani B, Dela Cruz LL, Chintalacharuvu K, Morrison SL. Analysis of a family of antibodies with different half-lives in mice fails to find a correlation between affinity for FcRn and serum half-life. Mol Immunol 2006;43:1462-1473.
114. Wypych J, etal. Human IgG2 antibodies display disulfide-mediated structural isoforms. J Biol Chem 2008;283:16194-16205.
115. Dillon TM, etal. Structural and functional characterization of disulfide isoforms of the human IgG2 subclass. J Biol Chem 2008;283:16206-16215.
116. Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 2006;313:670-673.
117. Tao MH, Morrison SL. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J Immunol 1989;143:2595-2601.
118. Bakchoul T, etal. Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia. Blood 2013;122:321-327.
119. Kapur R, etal. A prominent lack of IgG1-Fc fucosylation of plateletalloantibodies in pregnancy. Blood 2014;123:471-480.
120. Nimmerjahn F, Ravetch JV. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 2005;310:1510-1512.
121. Aschoff L. Das reticulo-endotheliale system. Erben Inn Med kinderheilk 1924;26:1.
122. Bai Y, etal. Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport. Proc Natl Acad Sci USA 2011;108:18406-18411.
123. Weflen AW, etal. Multivalent immune complexes divert FcRn to lysosomes by exclusion from recycling sorting tubules. Mol Biol Cell 2013;24:2398-2405.
124. Hsu VW, Bai M, Li J. Getting active: protein sorting in endocytic recycling. Nat Rev Mol Cell Biol 2012;13:323-328.
125. Schilling R, etal. Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen and virions. J Virol 2003;77:8882-8892.
126. Akilesh S, Christianson GJ, Roopenian DC, Shaw AS. Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism. J Immunol 2007;179:4580-4588.
127. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol 2001;19:275-290.
128. Morton HC, etal. Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR gamma chain. Molecular basis for CD89/FcR gamma chain association. J Biol Chem 1995;270:29781-29787.
129. Cox D, Chang P, Zhang Q, Reddy PG, Bokoch GM, Greenberg S. Requirements for both Rac1 and Cdc42 in membrane ruffling and phagocytosis in leukocytes. J Exp Med 1997;186:1487-1494.
130. Greenberg S, Chang P, Silverstein SC. Tyrosine phosphorylation is required for Fc receptor-mediated phagocytosis in mouse macrophages. J Exp Med 1993;177:529-534.
131. Greenberg S, Chang P, Silverstein SC. Tyrosine phosphorylation of the gamma subunit of Fc gamma receptors, p72syk, and paxillin during Fc receptor-mediated phagocytosis in macrophages. J Biol Chem 1994;269:3897-3902.
132. Vidarsson G, etal. Activity of human IgG and IgA subclasses in immune defense against Neisseria meningitidis serogroup B. J Immunol 2001;166:6250-6256.
133. Dechant M, etal. Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing. Blood 2002;100:4574-4580.
134. Monteiro RC, Van De Winkel JGJ. IgA Fc receptors. Annu Rev Immunol 2003;21:177-204.
135. Gul N, etal. Macrophages eliminate circulating tumor cells after monoclonal antibody therapy. J Clin Invest 2014;124:812-823.
136. Holowka D, Sil D, Torigoe C, Baird B. Insights into immunoglobulin E receptor signaling from structurally defined ligands. Immunol Rev 2007;217:269-279.
137. Hager M, Cowland JB, Borregaard N. Neutrophil granules in health and disease. J Intern Med 2010;268:25-34.
138. Diebolder CA, etal. Complement is activated by IgG hexamers assembled at the cell surface. Science 2014;343:1260-1263.
139. Shimizu A, etal. H NMR studies of the Fc region of human IgG1 and IgG3 immunoglobulins: assignment of histidine resonances in the CH3 domain and identification of IgG3 protein carrying G3m(st) allotypes. Mol Immunol 1983;20:141-148.
140. Segal AW, Geisow M, Garcia R, Harper A, Miller R. The respiratory burst of phagocytic cells is associated with a rise in vacuolar pH. Nature 1981;290:406-409.
141. + flux. Nature 2002;416:291-297.
142. Fairn GD, Grinstein S. How nascent phagosomes mature to become phagolysosomes. Trends Immunol 2012;33:397-405.
143. van Spriel AB, etal. Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation. Blood 2001;97:2478-2486.
144. Pryzwansky KB, MacRae EK, Spitznagel JK, Cooney MH. Early degranulation of human neutrophils: immunocytochemical studies of surface and intracellular phagocytic events. Cell 1979;18:1025-1033.
145. 2+-dependent tyrosine phosphorylation and microtubules. J Immunol 2002;168:5287-5296.
146. Tapper H, Grinstein S. Fc receptor-triggered insertion of secretory granules into the plasma membrane of human neutrophils: selective retrieval during phagocytosis. J Immunol 1997;159:409-418.
147. + dendritic cells. Proc Natl Acad Sci USA 2011;108:9927-9932.
148. Wines BD, Powell MS, Parren PW, Barnes N, Hogarth PM. The IgG Fc contains distinct Fc receptor (FcR) binding sites: the leukocyte receptors Fc gamma RI and Fc gamma RIIa bind to a region in the Fc distinct from that recognized by neonatal FcR and protein A. J Immunol 2000;164:5313-5318.
149. Braun V, etal. AP-1 and ARF1 control endosomal dynamics at sites of FcR mediated phagocytosis. Mol Biol Cell 2007;18:4921-4931.
150. Janvier K, etal. Recognition of dileucine-based sorting signals from HIV-1 Nef and LIMP-II by the AP-1 gamma-sigma1 and AP-3 delta-sigma3 hemicomplexes. J Cell Biol 2003;163:1281-1290.
151. Rodemer C, Haucke V. Clathrin/AP-2-dependent endocytosis: a novel playground for the pharmacological toolbox? Handb Exp Pharmacol 2008;186:105-122.
152. Traub LM. Tickets to ride: selecting cargo for clathrin-regulated internalization. Nat Rev Mol Cell Biol 2009;10:583-596.
153. Gold ES, Morrissette NS, Underhill DM, Guo J, Bassetti M, Aderem A. Amphiphysin IIm, a novel amphiphysin II isoform, is required for macrophage phagocytosis. Immunity 2000;12:285-292.
154. Gold ES, Underhill DM, Morrissette NS, Guo J, McNiven MA, Aderem A. Dynamin 2 is required for phagocytosis in macrophages. J Exp Med 1999;190:1849-1856.
155. Tse SM, etal. Differential role of actin, clathrin, and dynamin in Fc gamma receptor-mediated endocytosis and phagocytosis. J Biol Chem 2003;278:3331-3338.
156. Perry DG, Daugherty GL, Martin WJ 2nd. Clathrin-coated pit-associated proteins are required for alveolar macrophage phagocytosis. J Immunol 1999;162:380-386.
157. Crottet P, Meyer DM, Rohrer J, Spiess M. ARF1.GTP, tyrosine-based signals, and phosphatidylinositol 4, 5-bisphosphate constitute a minimal machinery to recruit the AP-1 clathrin adaptor to membranes. Mol Biol Cell 2002;13:3672-3682.
158. Lefkir Y, etal. Involvement of the AP-1 adaptor complex in early steps of phagocytosis and macropinocytosis. Mol Biol Cell 2004;15:861-869.
159. Vivier E, Nunes JA, Vely F. Natural killer cell signaling pathways. Science 2004;306:1517-1519.
160. Liu X, etal. The neonatal FcR-mediated presentation of immune-complexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells. J Immunol 2011;186:4674-4686.
161. Vegh A, Cervenak J, Jankovics I, Kacskovics I. FcRn overexpression in mice results in potent humoral response against weakly immunogenic antigen. MAbs 2011;3:173-180.
162. Cervenak J, etal. Neonatal FcR overexpression boosts humoral immune response in transgenic mice. J Immunol 2011;186:959-968.
163. Dumont JA, Bitonti AJ, Clark D, Evans S, Pickford M, Newman SP. Delivery of an erythropoietin-Fc fusion protein by inhalation in humans through an immunoglobulin transport pathway. J Aerosol Med 2005;18:294-303.
164. Lu L, etal. A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection. J Virol 2011;85:10542-10553.
165. Kruijsen D, etal. Intranasal administration of antibody-bound respiratory syncytial virus particles efficiently primes virus-specific immune responses in mice. J Virol 2013;87:7550-7557.
166. Rath T, Baker K, Pyzik M, Blumberg RS. Regulation of immune responses by the neonatal fc receptor and its therapeutic implications. Front Immunol 2014;5:664.
167. Baker K, etal. Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer. Immunity 2013;39:1095-1107.
168. Bubenik J. MHC class I down-regulation: tumour escape from immune surveillance? (review). Int J Oncol 2004;25:487-491.
169. Raghavan M, Chen MY, Gastinel LN, Bjorkman PJ. Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand. Immunity 1994;1:303-315.
170. Peterson PK, Verhoef J, Sabath LD, Quie PG. Effect of protein A on staphylococcal opsonization. Infect Immun 1977;15:760-764.
171. Dossett JH, Kronvall G, Williams RC Jr, Quie PG. Antiphagocytic effects of staphylococcal protein A. J Immunol 1969;103:1405-1410.
172. Kato K, etal. Model for the complex between protein G and an antibody Fc fragment in solution. Structure 1995;3:79-85.
173. Chapman TL, You I, Joseph IM, Bjorkman PJ, Morrison SL, Raghavan M. Characterization of the interaction between the herpes simplex virus type I Fc receptor and immunoglobulin G. J Biol Chem 1999;274:6911-6919.
174. Maillard P, etal. Fcgamma receptor-like activity of hepatitis C virus core protein. J Biol Chem 2004;279:2430-2437.
175. Chapman TL, Bjorkman PJ. Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog. J Virol 1998;72:460-466.
176. Beck S, Barrell BG. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 1988;331:269-272.
177. Browne H, Smith G, Beck S, Minson T. A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. Nature 1990;347:770-772.
178. Heyman B. Feedback regulation by IgG antibodies. Immunol Lett 2003;88:157-161.
179. Akilesh S, Petkova S, Sproule TJ, Shaffer DJ, Christianson GJ, Roopenian D. The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease. J Clin Invest 2004;113:1328-1333.
180. Martin WL, West AP Jr, Gan L, Bjorkman PJ. Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding. Mol Cell 2001;7:867-877.